AMG
57
2
PRU
59
5
MHK
46
3
MS
74
2
TMO
42
2
CTAS
64
2
BXP
60
6
SPG
50
4
EOG
46
14
DD
33
3
PFE
33
5
CFG
68
8
AMT
37
-4
EW
37
-4
FLR
62
4
IRM
52
2
ADP
79
2
DVN
29
2
HIG
66
6
EQT
50
5
AMG
57
2
PRU
59
5
MHK
46
3
MS
74
2
TMO
42
2
CTAS
64
2
BXP
60
6
SPG
50
4
EOG
46
14
DD
33
3
PFE
33
5
CFG
68
8
AMT
37
-4
EW
37
-4
FLR
62
4
IRM
52
2
ADP
79
2
DVN
29
2
HIG
66
6
EQT
50
5
Financhill
Back

The Oncology Institute 10K Form

Sell
28

TOI
The Oncology Institute

Last Price:
$2.60
Seasonality Move:
3.91%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive TOI News And Ratings

See the #1 stock for the next 7 days that we like better than TOI

TOI Financial Statistics

Sales & Book Value

Annual Sales: $393.4M
Cash Flow: $-5.3M
Price / Cash Flow: 0
Annual Sales: $0.06
Price / Book: 48.85

Profitability

EPS (TTM): -0.70000
Net Income (TTM): $-64.4M
Gross Margin: $54M
Return on Equity: -340.01%
Return on Assets: -35.75%

The Oncology Institute Earnings Forecast

Key The Oncology Institute Financial Ratios

  • The Gross Profit Margin over the past 6 years for TOI is 13.73%.
  • The Selling, General & Administrative Expenses for TOI have been equal to 27.41% of Gross Profit Margin.
  • The Net Earning history of TOI is -16.44% of Total Revenues.
  • Per Share Earnings over the last 6 years have been positive in 2 years.

The Oncology Institute Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Providers & Services
Sector: Health Care
Current Symbol: TOI
Website: theoncologyinstitute.com

Debt

Debt-to-Equity Ratio: 14.58
Current Ratio: 1.79
Quick Ratio: 1.5

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

TOI Technical Analysis vs Fundamental Analysis

Sell
28
The Oncology Institute (TOI) is a Sell

Is The Oncology Institute a Buy or a Sell?